1. Home
  2. XLO vs PODC Comparison

XLO vs PODC Comparison

Compare XLO & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • PODC
  • Stock Information
  • Founded
  • XLO 2016
  • PODC 2013
  • Country
  • XLO United States
  • PODC United States
  • Employees
  • XLO N/A
  • PODC N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • PODC
  • Sector
  • XLO Health Care
  • PODC
  • Exchange
  • XLO Nasdaq
  • PODC Nasdaq
  • Market Cap
  • XLO 42.2M
  • PODC 44.1M
  • IPO Year
  • XLO 2021
  • PODC N/A
  • Fundamental
  • Price
  • XLO $1.07
  • PODC $2.07
  • Analyst Decision
  • XLO Buy
  • PODC Strong Buy
  • Analyst Count
  • XLO 1
  • PODC 1
  • Target Price
  • XLO $4.00
  • PODC $5.00
  • AVG Volume (30 Days)
  • XLO 2.9M
  • PODC 12.3K
  • Earning Date
  • XLO 05-08-2025
  • PODC 06-10-2025
  • Dividend Yield
  • XLO N/A
  • PODC N/A
  • EPS Growth
  • XLO N/A
  • PODC N/A
  • EPS
  • XLO N/A
  • PODC N/A
  • Revenue
  • XLO $9,274,000.00
  • PODC $49,729,000.00
  • Revenue This Year
  • XLO $299.61
  • PODC $20.67
  • Revenue Next Year
  • XLO $1.99
  • PODC $19.09
  • P/E Ratio
  • XLO N/A
  • PODC N/A
  • Revenue Growth
  • XLO N/A
  • PODC 22.98
  • 52 Week Low
  • XLO $0.62
  • PODC $1.10
  • 52 Week High
  • XLO $1.70
  • PODC $2.85
  • Technical
  • Relative Strength Index (RSI)
  • XLO 64.52
  • PODC 55.40
  • Support Level
  • XLO $0.86
  • PODC $1.88
  • Resistance Level
  • XLO $0.92
  • PODC $2.14
  • Average True Range (ATR)
  • XLO 0.11
  • PODC 0.18
  • MACD
  • XLO 0.02
  • PODC -0.01
  • Stochastic Oscillator
  • XLO 77.18
  • PODC 78.26

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: